Amyloidosis secondary to rheumatic diseases - 16 cases

Acta Reumatologica Portuguesa

Volumn 35, Issue 4, 2010, Pages 518-523

  Silva, Lígia ^a   Sampaio, Luzia ^a   Terroso, Georgina ^a   Almeida, Gabriela ^a   Lucas, Raquel ^b   Rios, Elisabete ^c   Bernardes, J Miguel ^a   Bernardo, Alexandra ^a   Mariz, Eva ^a   Brito, Iva ^a   Pinto, José ^a   Maia, Céu ^a   Brito, J Silva ^a   Ventura, Francisco S ^b  

^a Reumatologia do Hospital   (Portugal)

^b University of Porto   (Portugal)

^c Internato Complementar   (Portugal)

Author keywords

Amyloid A; Rheumatic diseases; Secondary amyloidosis

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; RHEUMATIC DISEASE;

ADULT; AGED; AMYLOIDOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RHEUMATIC DISEASES;

EID: 79251522866     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596.
2. Nakamura T. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol 2008;18:109-118.
3. Gorevic P. An overview of amyloidosis. In: UpToDate, Schur PH (Ed), UpToDate 2010. Accessed at 4 June 2010.
4. Hazenberg B, Van Rijswijk M. Where has secondary amyloid gone? Ann Rheum Dis 2000;59:577-579.
5. Tuglular S, Yalcinkaya F, Paydas S et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 2002;17:2003-2005.
6. Lachmann HJ, Goodman HJ, Gilbertson JÁ, Gallimore JR, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;23:2361-2367.
7. Gorevic P. Causes and diagnosis of secondary (AA) amyloidosis and relation to rheumatic diseases. In: UpToDate, Schur PH (Ed), UpToDate 2010. Accessed at 4 June 2010.
8. Monteiro R Abreu P Salvador MI, Malcata A. Amiloidose secundária e Lúpus eritematoso sistémico. Acta Reumatol Port 2009;34:400-4004.
9. Gómez-Casanovas E, Sanmartí R, Solé M, Cañete ID, Muñoz-Gomez J. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration. Arthritis Rheum 2001;44:66-72.
10. Younes M, Korbaa W, Moussa A et al. Prevalence of subclinical amyloidosis in Tunisian patients with rheumatoid arthritis. Joint Bone Spine 2009;76:254-259.
11. Wakhlu A, Krisnani N, Hissaria P Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol 2003;30:948-951.
12. Alishiri GH, Salimzadeh A, Owlia MB, Forghanizadeh I, Setarehshenas R, Shayanfar N. Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics. BMC Musculoskeletal Disorders Published Online First: 15 May 2006. doi:10.1186/1471-2474-7-43.
13. Joss N, McLaughlin K, Simpson K, Boulton-Jones J.M. Presentation, survival and prognostic markers in AA amyloidosis. QI Med 2000;93:535-542
14. Takeshi Kuroda T, Tanabe N, Harada T et al. Longterm mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2006;25:498-505.
15. Okuda Y, Takasugi K, Oyama T, Onuma M, Oyama H. Amyloidosis in rheumatoid arthritis: clinical study of 124 histologically proven cases. Ryumachi 1994;34: 939-946.
16. Pettersson T, Konttinen YT. Amyloidosis-Recent Developments. Semin Arthritis Rheum 2010;39:356-368.
17. Laiho K, Tiitinen S, Kaarela K, Helin H, Isomaki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999; 18:122-123.
18. Thorn CF, Lu ZY, Whitehead AS. Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol 2004;59:152-158.
19. Okuda Y. Review of tocilizumab in the treatment of rheumatoid arthritis. Biologies 2008;2:75-82.
20. Kobak S. Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis. Rheumatol Int Published Online First: 26 March 2010. doi: 10.1007/s00296-010-1457-7.
21. Nakamura T, Higashi SI, Tomoda K, Tsukano M, Shono M. Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Clin Rheumatol Published Online First: 5 May 2010. doi: 10.1007/s10067-010-1469-4.
22. Dember LM. Modern treatment of amyloidosis: unresolved questions. J Am Soc Nephrol 2009;20:469-472.
23. Gorevic P. Pathogenesis of secondary (AA) amyloidosis. In: UpToDate, Schur PH (Ed), UpToDate 2010. Accessed at 4 June 2010.
24. Gilmore JD, Hawkins PN. Drug Insight: emerging therapies for amyloidosis. Nat Clin Pract Nephrol 2006; 2:263-270.